Promoter Analysis of a Human Dihydrodiol Dehydrogenase
Paul J. Ciaccio(Fox Chase Cancer Center), Kenneth D. Tew(Medical University of South Carolina), Eileen S. Walsh(Janssen (Switzerland))
Cited by 18
Related Papers
A T-cell–redirecting bispecific G-protein–coupled receptor class 5 member D x CD3 antibody to treat multiple myeloma
|Blood|2020|167
Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2<i>S</i>)-4-(2,5-Difluorophenyl)-<i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-<i>N</i>-methyl-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer
|Journal of Medicinal Chemistry|2008|157
Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP
|Bioorganic & Medicinal Chemistry Letters|2005|137
PABA/NO as an Anticancer Lead: Analogue Synthesis, Structure Revision, Solution Chemistry, Reactivity toward Glutathione, and in Vitro Activity
|Journal of Medicinal Chemistry|2006|92
3-Aminopyrrolidinone Farnesyltransferase Inhibitors: Design of Macrocyclic Compounds with Improved Pharmacokinetics and Excellent Cell Potency
|Journal of Medicinal Chemistry|2002|86